(Q33899850)

29 July 2017

1 reference

title

Endogenous cannabinoid signaling and psychomotor disorders (English)

1 reference

29 July 2017

0 references

1 reference

Giuffrida A

1

1 reference

PubMed ID

10785542

29 July 2017

Désarnaud F

series ordinal

2

1 reference

PubMed ID

10785542

29 July 2017

Piomelli D

series ordinal

3

1 reference

29 July 2017

1 April 2000

1 reference

Prostaglandins and Other Lipid Mediators

29 July 2017

1 reference

29 July 2017

61

1 reference

29 July 2017

63-70

1 reference

29 July 2017

1-2

1 reference

Role of the endogenous cannabinoid system in the regulation of motor activity.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Localization of cannabinoid receptor mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Brain cannabinoid systems as targets for the therapy of neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

The functional neuroanatomy of brain cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Endogenous cannabinoid signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Structural determinants for recognition and translocation by the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

The basal ganglia and adaptive motor control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Cannabinoid receptor localization in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Biphasic effect of D-2 agonist quinpirole on locomotion and movements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

The metabolic anatomy of Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Chemical brain anatomy in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

1 reference

7 January 2021

Neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900055-1

7 January 2021

10.1016/S0090-6980(00)00055-1

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10785542